{
    "2018-06-07": [
        [
            {
                "time": "",
                "original_text": "[强烈推荐-A评级] 昭衍新药(603127)点评：携手凯莱英 开展产业链深度合作",
                "features": {
                    "keywords": [
                        "昭衍新药",
                        "凯莱英",
                        "产业链",
                        "深度合作"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物技术"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[买入评级] 凯莱英(002821)重大事项点评：联手国内外龙头 共同打造一站式服务体系",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "国内外龙头",
                        "一站式服务"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "昭衍新药与凯莱英签署战略合作 形成良性业务循环",
                "features": {
                    "keywords": [
                        "昭衍新药",
                        "凯莱英",
                        "战略合作",
                        "良性循环"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "研发生产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[强烈推荐评级] 凯莱英(002821)事项点评：战略合作CRO 持续强化新药研发生产一站式服务",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "战略合作",
                        "CRO",
                        "新药研发",
                        "一站式服务"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "研发外包"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}